Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) dropped 5.7% on Friday . The stock traded as low as $312.18 and last traded at $312.43. 129,244 shares were traded during trading, a decline of 78% from the average session volume of 574,853 shares. The stock had previously closed at $331.23.
Direxion Daily S&P Biotech Bull 3x Shares Stock Down 9.5%
The company has a 50 day moving average price of $276.35 and a 200-day moving average price of $209.53.
Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Institutional investors and hedge funds have recently made changes to their positions in the business. Qube Research & Technologies Ltd purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the second quarter valued at approximately $26,000. Ramsey Quantitative Systems purchased a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter worth approximately $41,000. Headlands Technologies LLC bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 2nd quarter valued at about $69,000. Covestor Ltd acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter worth $71,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the first quarter worth about $166,000.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Articles
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
- BWX Technologies’ Army Reactor Win Could Redraw Its Nuclear Growth Story
- Meta’s $18 Billion Settlement May Be a Win for Investors
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
